Cerebrovascular Disease Is a Major Factor in the Failure of Elimination of Aβ from the Aging Human Brain: Implications for Therapy of Alzheimer's Disease
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
A bstract: Alzheimer's disease (AD) is characterized by the intracellular deposition of ubiquitinated tau and by the extracellular accumulation of soluble, insoluble, and fibrillary Aβ. Previous studies suggest that Aβ is normally eliminated from the brain along perivascular pathways that may become blocked in the aging brain, resulting in cerebral amyloid angiopathy. As age is a major risk factor for AD and for cerebrovascular disease (CVD), we test the hypothesis that CVD inhibits the elimination of Aβ from the aging human brain. Sections from 100 aged and AD brains were stained for Aβ by immunohistochemistry and by reticulin and Masson trichrome techniques. Early deposition of Aβ in brain parenchyma was related to individual arterial territories in the cortex. In areas of more extensive accumulation of Aβ, there was an inverse relationship between capillary amyloid angiopathy and plaques of Aβ. Thus, arterial territories with extensive capillary amyloid angiopathy were devoid of Aβ plaques, whereas in areas with abundant diffuse plaques there was no capillary amyloid angiopathy. Serial sections showed that cortical arteries feeding capillary beds with Aβ angiopathy were occluded by thrombus. We conclude that CVD inhibits the elimination of Aβ along capillary walls and changes the distribution of Aβ in the cerebral cortex. Loss of pulsations in thrombosed or arteriosclerotic arteries may thus abolish the motive force necessary for the drainage of Aβ and inhibit the elimination of Aβ. Therapies to increase elimination of Aβ in AD need to consider the effects of CVD on the elimination of Aβ from the aging human brain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer's Disease
Lue, L.-F., Kuo, Y.-M., Roher, A. E., Brachova, L., Shen, Y., Sue, L., Beach, T., Kurth, J. H., Rydel, R. E., & Rogers, J. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65184-x · Cited by 1,530
Aβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease
Janus, C., Pearson, J., McLaurin, J., Mathews, P. M., Jiang, Y., Schmidt, S. D., Chishti, M. A., Horne, P., Heslin, D., French, J., et al. (2000) · Nature · doi:10.1038/35050110 · Cited by 1,431
Neuropathologic Substrates of Ischemic Vascular Dementia
Vinters, H. V., Ellis, W. G., Zarow, C., Zaias, B. W., Jagust, W. J., Mack, W. J., & Chui, H. C. (2000) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/59.11.931 · Cited by 304
Weller, R. O. (1998) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199810000-00001 · Cited by 224
Self-citationMcCarron, M. O., Nicoll, J. A. R., Stewart, J., Ironside, J. W., Mann, D. M. A., Love, S., Graham, D. I., & Dewar, D. (1999) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199907000-00005 · Cited by 160
Self-citationShinkai, Y., Yoshimura, M., Ito, Y., Odaka, A., Suzuki, N., Yanagisawa, K., & Ihara, Y. (1995) · Annals of Neurology · doi:10.1002/ana.410380312 · Cited by 127
Cited by
Neuropathology of human Alzheimer disease after immunization with amyloid-β peptide: a case report
Nicoll, J. A. R., Wilkinson, D., Holmes, C., Steart, P., Markham, H., & Weller, R. O. (2003) · Nature Medicine · doi:10.1038/nm840 · Cited by 1,397
Self-citationCerebral amyloid angiopathy and Alzheimer disease — one peptide, two pathways
Greenberg, S. M., Bacskai, B. J., Hernandez-Guillamon, M., Pruzin, J., Sperling, R., & van Veluw, S. J. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-019-0281-2 · Cited by 947
Charidimou, A., Gang, Q., & Werring, D. J. (2012) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2011-301308 · Cited by 611
Davis, J., Xu, F., Deane, R., Romanov, G., Previti, M. L., Zeigler, K., Zlokovic, B. V., & Van Nostrand, W. E. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312946200 · Cited by 373
Mechanisms to explain the reverse perivascular transport of solutes out of the brain
Schley, D., Carare-Nnadi, R., Please, C. P., Perry, V. H., & Weller, R. O. (2006) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2005.07.005 · Cited by 293
Self-citation
Metadata
- Authors
- WELLER, R. O., YOW, H., PRESTON, S. D., MAZANTI, I., & NICOLL, J. A. R.
- Venue
- Annals of the New York Academy of Sciences
- Publisher
- Wiley
- Published
- 2002-11
- Volume
- 977
- Issue
- 1
- Pages
- 162-168
- ISSN
- 0077-8923 (ISSN-L)
- 1749-6632
- OpenAlex
- W2140260680
- Cited by
- 82
- References
- 6
- FWCI
- 3.67
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cerebrovascular Disease Is a Major Factor in the Failure of Elimination of Aβ from the Aging Human Brain: Implications for Therapy of Alzheimer's Disease. https://app.cochat.ai/papers/10.1111/j.1749-6632.2002.tb04812.x
- The paper
- WELLER, R. O., YOW, H., PRESTON, S. D., MAZANTI, I., & NICOLL, J. A. R. (2002). Cerebrovascular Disease Is a Major Factor in the Failure of Elimination of Aβ from the Aging Human Brain: Implications for Therapy of Alzheimer's Disease. Annals of the New York Academy of Sciences. https://doi.org/10.1111/j.1749-6632.2002.tb04812.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.